-
1
-
-
29144508843
-
Global prevalence of dementia: a Delphi consensus study
-
PID: 16360788
-
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–7.
-
(2005)
Lancet.
, vol.366
, pp. 2112-2117
-
-
Ferri, C.P.1
Prince, M.2
Brayne, C.3
Brodaty, H.4
Fratiglioni, L.5
Ganguli, M.6
-
2
-
-
84875354777
-
2013 Alzheimer’s disease facts and figures
-
10.1016/j.jalz.2013.02.003
-
Thies W, Bleiler L. 2013 Alzheimer’s disease facts and figures. Alzheimers Dement. 2013;9:208–45. doi:10.1016/j.jalz.2013.02.003.
-
(2013)
Alzheimers Dement.
, vol.9
, pp. 208-245
-
-
Thies, W.1
Bleiler, L.2
-
3
-
-
79956125839
-
Biomarkers in Alzheimer’s disease drug development
-
COI: 1:CAS:528:DC%2BC3MXmtVyjsr0%3D, PID: 21550318, 10.1016/j.jalz.2010.06.004
-
Cummings JL. Biomarkers in Alzheimer’s disease drug development. Alzheimers Dement. 2011;7:e13–44. doi:10.1016/j.jalz.2010.06.004.
-
(2011)
Alzheimers Dement.
, vol.7
, pp. e13-e44
-
-
Cummings, J.L.1
-
4
-
-
82755193805
-
Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression
-
COI: 1:CAS:528:DC%2BC3MXhsFygtbjJ, PID: 21601614, 10.1016/j.pneurobio.2011.05.004
-
Teipel SJ, Buchert R, Thome J, Hampel H, Pahnke J. Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression. Prog Neurobiol. 2011;95:547–56. doi:10.1016/j.pneurobio.2011.05.004.
-
(2011)
Prog Neurobiol.
, vol.95
, pp. 547-556
-
-
Teipel, S.J.1
Buchert, R.2
Thome, J.3
Hampel, H.4
Pahnke, J.5
-
5
-
-
79952793175
-
Amyloid beta (Abeta) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer’s disease
-
COI: 1:CAS:528:DC%2BC3MXms1Wnu7w%3D, PID: 21342022, 10.1515/CCLM.2011.087
-
Prvulovic D, Hampel H. Amyloid beta (Abeta) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer’s disease. Clin Chem Lab Med. 2011;49:367–74. doi:10.1515/CCLM.2011.087.
-
(2011)
Clin Chem Lab Med.
, vol.49
, pp. 367-374
-
-
Prvulovic, D.1
Hampel, H.2
-
6
-
-
82755161905
-
Biomarkers for Alzheimer’s disease therapeutic trials
-
COI: 1:CAS:528:DC%2BC3MXhsFygtbjK, PID: 21130138, 10.1016/j.pneurobio.2010.11.005
-
Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, et al. Biomarkers for Alzheimer’s disease therapeutic trials. Prog Neurobiol. 2011;95:579–93. doi:10.1016/j.pneurobio.2010.11.005.
-
(2011)
Prog Neurobiol.
, vol.95
, pp. 579-593
-
-
Hampel, H.1
Wilcock, G.2
Andrieu, S.3
Aisen, P.4
Blennow, K.5
Broich, K.6
-
7
-
-
67349184808
-
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease
-
PID: 19376612, 10.1016/j.neurobiolaging.2009.04.002
-
Price JL, McKeel Jr DW, Buckles VD, Roe CM, Xiong C, Grundman M, et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging. 2009;30:1026–36. doi:10.1016/j.neurobiolaging.2009.04.002.
-
(2009)
Neurobiol Aging.
, vol.30
, pp. 1026-1036
-
-
Price, J.L.1
McKeel, D.W.2
Buckles, V.D.3
Roe, C.M.4
Xiong, C.5
Grundman, M.6
-
8
-
-
10744232413
-
Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B
-
COI: 1:CAS:528:DC%2BD2cXisFKntb8%3D, PID: 14991808
-
Klunk W, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt D, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306–19.
-
(2004)
Ann Neurol.
, vol.55
, pp. 306-319
-
-
Klunk, W.1
Engler, H.2
Nordberg, A.3
Wang, Y.4
Blomqvist, G.5
Holt, D.6
-
9
-
-
4644283049
-
PET imaging of amyloid in Alzheimer’s disease
-
COI: 1:CAS:528:DC%2BD2cXnvFKjtL4%3D, PID: 15324720
-
Nordberg A. PET imaging of amyloid in Alzheimer’s disease. Lancet Neurol. 2004;3:519–27.
-
(2004)
Lancet Neurol.
, vol.3
, pp. 519-527
-
-
Nordberg, A.1
-
10
-
-
15944366880
-
In vivo imaging of Alzheimer disease b-amyloid with [13C]SB-13 PET
-
PID: 15545326
-
Verhoeff N, Wilson A, Takeshita S, Trop L, Hussey D, Singh K, et al. In vivo imaging of Alzheimer disease b-amyloid with [13C]SB-13 PET. Am J Geriatr Psychiatry. 2004;12:584–95.
-
(2004)
Am J Geriatr Psychiatry.
, vol.12
, pp. 584-595
-
-
Verhoeff, N.1
Wilson, A.2
Takeshita, S.3
Trop, L.4
Hussey, D.5
Singh, K.6
-
11
-
-
70350716476
-
Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain
-
COI: 1:CAS:528:DC%2BD1MXhsVyqs7rK, PID: 19837759, 10.2967/jnumed.109.065284
-
Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F, et al. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. J Nucl Med. 2009;50:1887–94. doi:10.2967/jnumed.109.065284.
-
(2009)
J Nucl Med.
, vol.50
, pp. 1887-1894
-
-
Choi, S.R.1
Golding, G.2
Zhuang, Z.3
Zhang, W.4
Lim, N.5
Hefti, F.6
-
12
-
-
84877041796
-
Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for beta-amyloid imaging in aging and dementia
-
COI: 1:CAS:528:DC%2BC3sXpvFeisbg%3D, PID: 23575995, 10.2967/jnumed.112.114785
-
Rowe CC, Pejoska S, Mulligan RS, Jones G, Chan JG, Svensson S, et al. Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for beta-amyloid imaging in aging and dementia. J Nucl Med. 2013;54:880–6. doi:10.2967/jnumed.112.114785.
-
(2013)
J Nucl Med.
, vol.54
, pp. 880-886
-
-
Rowe, C.C.1
Pejoska, S.2
Mulligan, R.S.3
Jones, G.4
Chan, J.G.5
Svensson, S.6
-
13
-
-
84858607421
-
Clinical validation of 18F-AZD4694, an amyloid-beta-specific PET radioligand
-
COI: 1:CAS:528:DC%2BC38XlvVGhurk%3D, PID: 22323782, 10.2967/jnumed.111.094029
-
Cselenyi Z, Jonhagen ME, Forsberg A, Halldin C, Julin P, Schou M, et al. Clinical validation of 18F-AZD4694, an amyloid-beta-specific PET radioligand. J Nucl Med. 2012;53:415–24. doi:10.2967/jnumed.111.094029.
-
(2012)
J Nucl Med.
, vol.53
, pp. 415-424
-
-
Cselenyi, Z.1
Jonhagen, M.E.2
Forsberg, A.3
Halldin, C.4
Julin, P.5
Schou, M.6
-
14
-
-
84862529821
-
Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies
-
COI: 1:CAS:528:DC%2BC38XkvFymur8%3D, PID: 22270508, 10.1007/s00259-011-2051-2
-
Hsiao IT, Huang CC, Hsieh CJ, Hsu WC, Wey SP, Yen TC, et al. Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies. Eur J Nucl Med Mol Imaging. 2012;39:613–20. doi:10.1007/s00259-011-2051-2.
-
(2012)
Eur J Nucl Med Mol Imaging.
, vol.39
, pp. 613-620
-
-
Hsiao, I.T.1
Huang, C.C.2
Hsieh, C.J.3
Hsu, W.C.4
Wey, S.P.5
Yen, T.C.6
-
15
-
-
66149104129
-
Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging
-
COI: 1:CAS:528:DC%2BD1MXmtV2hsrk%3D, PID: 19372469, 10.2967/jnumed.108.060756
-
Koole M, Lewis DM, Buckley C, Nelissen N, Vandenbulcke M, Brooks DJ, et al. Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. J Nucl Med. 2009;50:818–22. doi:10.2967/jnumed.108.060756.
-
(2009)
J Nucl Med.
, vol.50
, pp. 818-822
-
-
Koole, M.1
Lewis, D.M.2
Buckley, C.3
Nelissen, N.4
Vandenbulcke, M.5
Brooks, D.J.6
-
16
-
-
68249141258
-
Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease
-
COI: 1:CAS:528:DC%2BD1MXhtVymtrrJ, PID: 19617318, 10.2967/jnumed.109.063305
-
Nelissen N, Van Laere K, Thurfjell L, Owenius R, Vandenbulcke M, Koole M, et al. Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease. J Nucl Med. 2009;50:1251–9. doi:10.2967/jnumed.109.063305.
-
(2009)
J Nucl Med.
, vol.50
, pp. 1251-1259
-
-
Nelissen, N.1
Van Laere, K.2
Thurfjell, L.3
Owenius, R.4
Vandenbulcke, M.5
Koole, M.6
-
17
-
-
38149081191
-
Imaging of amyloid beta in Alzheimer’s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
-
COI: 1:CAS:528:DC%2BD1cXis1WmsLw%3D, PID: 18191617, 10.1016/S1474-4422(08)70001-2
-
Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O’Keefe G, et al. Imaging of amyloid beta in Alzheimer’s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 2008;7:129–35. doi:10.1016/S1474-4422(08)70001-2.
-
(2008)
Lancet Neurol
, vol.7
, pp. 129-135
-
-
Rowe, C.C.1
Ackerman, U.2
Browne, W.3
Mulligan, R.4
Pike, K.L.5
O’Keefe, G.6
-
18
-
-
80051688987
-
Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias
-
PID: 21764791, 10.2967/jnumed.111.089730
-
Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, et al. Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. J Nucl Med. 2011;52:1210–7. doi:10.2967/jnumed.111.089730.
-
(2011)
J Nucl Med.
, vol.52
, pp. 1210-1217
-
-
Villemagne, V.L.1
Ong, K.2
Mulligan, R.S.3
Holl, G.4
Pejoska, S.5
Jones, G.6
-
19
-
-
84877106494
-
PET quantification of 18F-florbetaben binding to beta-amyloid deposits in human brains
-
COI: 1:CAS:528:DC%2BC3sXosFCnsL4%3D, PID: 23471310, 10.2967/jnumed.112.107185
-
Becker GA, Ichise M, Barthel H, Luthardt J, Patt M, Seese A, et al. PET quantification of 18F-florbetaben binding to beta-amyloid deposits in human brains. J Nucl Med. 2013;54:723–31. doi:10.2967/jnumed.112.107185.
-
(2013)
J Nucl Med.
, vol.54
, pp. 723-731
-
-
Becker, G.A.1
Ichise, M.2
Barthel, H.3
Luthardt, J.4
Patt, M.5
Seese, A.6
-
20
-
-
77953937194
-
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)
-
COI: 1:CAS:528:DC%2BC3cXosl2ksb4%3D, PID: 20501908, 10.2967/jnumed.109.069088
-
Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med. 2010;51:913–20. doi:10.2967/jnumed.109.069088.
-
(2010)
J Nucl Med.
, vol.51
, pp. 913-920
-
-
Wong, D.F.1
Rosenberg, P.B.2
Zhou, Y.3
Kumar, A.4
Raymont, V.5
Ravert, H.T.6
-
21
-
-
84879980176
-
Amyloid tracers detect multiple binding sites in Alzheimer’s disease brain tissue
-
PID: 23757761, 10.1093/brain/awt142
-
Ni R, Gillberg PG, Bergfors A, Marutle A, Nordberg A. Amyloid tracers detect multiple binding sites in Alzheimer’s disease brain tissue. Brain. 2013;136:2217–27. doi:10.1093/brain/awt142.
-
(2013)
Brain.
, vol.136
, pp. 2217-2227
-
-
Ni, R.1
Gillberg, P.G.2
Bergfors, A.3
Marutle, A.4
Nordberg, A.5
-
22
-
-
14844303913
-
Evidence for presence of three distinct binding sites for thioflavin T class of Alzheimer’s disease PET imaging agents on b-amyloid peptide fibrils
-
COI: 1:CAS:528:DC%2BD2MXhs1yisLY%3D, PID: 15615711
-
Lockhart A, Ye L, Judd D, Meritt A, Lowe P, Morgenstern J, et al. Evidence for presence of three distinct binding sites for thioflavin T class of Alzheimer’s disease PET imaging agents on b-amyloid peptide fibrils. J Biol Chem. 2005;280:7677–84.
-
(2005)
J Biol Chem.
, vol.280
, pp. 7677-7684
-
-
Lockhart, A.1
Ye, L.2
Judd, D.3
Meritt, A.4
Lowe, P.5
Morgenstern, J.6
-
23
-
-
84904568939
-
Characterization of a brain permeant fluorescent molecule and visualization of Aβ parenchymal plaques, using real-time multiphoton imaging in transgenic mice
-
COI: 1:CAS:528:DC%2BC2cXhtFajsbjL, PID: 25003699
-
Sundaram GSM, Garai K, Rath NP, Yan P, Cirrito JR, Cairns N, et al. Characterization of a brain permeant fluorescent molecule and visualization of Aβ parenchymal plaques, using real-time multiphoton imaging in transgenic mice. Org Lett. 2014;16:3640–3.
-
(2014)
Org Lett.
, vol.16
, pp. 3640-3643
-
-
Sundaram, G.S.M.1
Garai, K.2
Rath, N.P.3
Yan, P.4
Cirrito, J.R.5
Cairns, N.6
-
24
-
-
84994347306
-
Design and synthesis of a novel PET probe for early detection of Alzheimer’s disease
-
Sundaram GSM, Cairns N, Lee J-M, Sharma V. Design and synthesis of a novel PET probe for early detection of Alzheimer’s disease. J Nucl Med. 2014;55:137.
-
(2014)
J Nucl Med.
, vol.55
, pp. 137
-
-
Sundaram, G.S.M.1
Cairns, N.2
Lee, J.-M.3
Sharma, V.4
-
25
-
-
2542457758
-
Synthesis of [18F]Fluorocholine analogues as potential imaging agents for PET studies
-
COI: 1:CAS:528:DC%2BD2cXktFyhsbk%3D
-
Yu K, Park J, Yang S. Synthesis of [18F]Fluorocholine analogues as potential imaging agents for PET studies. Bull Korean Chem Soc. 2004;25:506–10.
-
(2004)
Bull Korean Chem Soc.
, vol.25
, pp. 506-510
-
-
Yu, K.1
Park, J.2
Yang, S.3
-
26
-
-
84873564460
-
Binding of the radioligand SIL23 to alpha-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent
-
COI: 1:CAS:528:DC%2BC3sXivFGqs74%3D, PID: 23405108, 10.1371/journal.pone.0055031
-
Bagchi DP, Yu L, Perlmutter JS, Xu J, Mach RH, Tu Z, et al. Binding of the radioligand SIL23 to alpha-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent. PLoS One. 2013;8:e55031. doi:10.1371/journal.pone.0055031.
-
(2013)
PLoS One.
, vol.8
, pp. e55031
-
-
Bagchi, D.P.1
Yu, L.2
Perlmutter, J.S.3
Xu, J.4
Mach, R.H.5
Tu, Z.6
-
27
-
-
77956698237
-
Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer’s disease research
-
COI: 1:CAS:528:DC%2BC3cXnsFSktL8%3D, PID: 20539293, 10.1038/nprot.2010.72
-
Jan A, Hartley DM, Lashuel HA. Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer’s disease research. Nat Protoc. 2010;5:1186–209. doi:10.1038/nprot.2010.72.
-
(2010)
Nat Protoc.
, vol.5
, pp. 1186-1209
-
-
Jan, A.1
Hartley, D.M.2
Lashuel, H.A.3
-
28
-
-
27944471285
-
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer’s disease brain but not in transgenic mouse brain
-
COI: 1:CAS:528:DC%2BD2MXht1Kqsb%2FP, PID: 16291932
-
Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE, et al. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer’s disease brain but not in transgenic mouse brain. J Neurosci. 2005;25:10598–606.
-
(2005)
J Neurosci.
, vol.25
, pp. 10598-10606
-
-
Klunk, W.E.1
Lopresti, B.J.2
Ikonomovic, M.D.3
Lefterov, I.M.4
Koldamova, R.P.5
Abrahamson, E.E.6
-
29
-
-
84887416188
-
[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease
-
PID: 23411393, 10.1016/j.jalz.2012.11.008
-
Xia CF, Arteaga J, Chen G, Gangadharmath U, Gomez LF, Kasi D, et al. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease. Alzheimers Dement. 2013;9:666–76. doi:10.1016/j.jalz.2012.11.008.
-
(2013)
Alzheimers Dement
, vol.9
, pp. 666-676
-
-
Xia, C.F.1
Arteaga, J.2
Chen, G.3
Gangadharmath, U.4
Gomez, L.F.5
Kasi, D.6
-
30
-
-
84859064398
-
Bidirectional relationship between functional connectivity and amyloid-beta deposition in mouse brain
-
COI: 1:CAS:528:DC%2BC38Xlt1ehtL0%3D, PID: 22457485, 10.1523/JNEUROSCI.5845-11.2012
-
Bero AW, Bauer AQ, Stewart FR, White BR, Cirrito JR, Raichle ME, et al. Bidirectional relationship between functional connectivity and amyloid-beta deposition in mouse brain. J Neurosci. 2012;32:4334–40. doi:10.1523/JNEUROSCI.5845-11.2012.
-
(2012)
J Neurosci.
, vol.32
, pp. 4334-4340
-
-
Bero, A.W.1
Bauer, A.Q.2
Stewart, F.R.3
White, B.R.4
Cirrito, J.R.5
Raichle, M.E.6
-
31
-
-
84876569513
-
Blocking the interaction between apolipoprotein E and Abeta reduces intraneuronal accumulation of Abeta and inhibits synaptic degeneration
-
COI: 1:CAS:528:DC%2BC3sXmtlCrurc%3D, PID: 23499462, 10.1016/j.ajpath.2013.01.034
-
Kuszczyk MA, Sanchez S, Pankiewicz J, Kim J, Duszczyk M, Guridi M, et al. Blocking the interaction between apolipoprotein E and Abeta reduces intraneuronal accumulation of Abeta and inhibits synaptic degeneration. Am J Pathol. 2013;182:1750–68. doi:10.1016/j.ajpath.2013.01.034.
-
(2013)
Am J Pathol.
, vol.182
, pp. 1750-1768
-
-
Kuszczyk, M.A.1
Sanchez, S.2
Pankiewicz, J.3
Kim, J.4
Duszczyk, M.5
Guridi, M.6
-
32
-
-
77953578223
-
Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport
-
COI: 1:CAS:528:DC%2BC3cXnsVWhuro%3D, PID: 20505882
-
Sivapackiam J, Harpstrite SE, Prior JL, Gu H, Rath NP, Sharma V. Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport. Dalton Trans. 2010;39:5842–50.
-
(2010)
Dalton Trans.
, vol.39
, pp. 5842-5850
-
-
Sivapackiam, J.1
Harpstrite, S.E.2
Prior, J.L.3
Gu, H.4
Rath, N.P.5
Sharma, V.6
-
33
-
-
70349967829
-
Efficient and economical access to substituted benzothiazoles: copper-catalyzed coupling of 2-haloanilides with metal sulfides and subsequent condensation
-
COI: 1:CAS:528:DC%2BD1MXmsVSis7k%3D, PID: 19425042, 10.1002/anie.200900486
-
Ma D, Xie S, Xue P, Zhang X, Dong J, Jiang Y. Efficient and economical access to substituted benzothiazoles: copper-catalyzed coupling of 2-haloanilides with metal sulfides and subsequent condensation. Angew Chem Int Ed Engl. 2009;48:4222–5. doi:10.1002/anie.200900486.
-
(2009)
Angew Chem Int Ed Engl.
, vol.48
, pp. 4222-4225
-
-
Ma, D.1
Xie, S.2
Xue, P.3
Zhang, X.4
Dong, J.5
Jiang, Y.6
-
34
-
-
0038792263
-
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents
-
COI: 1:CAS:528:DC%2BD3sXjvFOiurg%3D, PID: 12801237
-
Mathis C, Wang Y, Holt D, Huang G, Debnath M, Klunk W. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem. 2003;46:2740–54.
-
(2003)
J Med Chem.
, vol.46
, pp. 2740-2754
-
-
Mathis, C.1
Wang, Y.2
Holt, D.3
Huang, G.4
Debnath, M.5
Klunk, W.6
-
36
-
-
84932646364
-
-
ID: 3473704. 2014.
-
http://www.accessdata.fda.gov/…/204677s000lb/search/Reference ID: 3473704. 2014.
-
-
-
-
37
-
-
84868317595
-
Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-beta
-
COI: 1:CAS:528:DC%2BC3sXnslWhsw%3D%3D, PID: 23008501, 10.2967/jnumed.112.104810
-
Brockschnieder D, Schmitt-Willich H, Heinrich T, Varrone A, Gulyas B, Toth M, et al. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-beta. J Nucl Med. 2012;53:1794–801. doi:10.2967/jnumed.112.104810.
-
(2012)
J Nucl Med.
, vol.53
, pp. 1794-1801
-
-
Brockschnieder, D.1
Schmitt-Willich, H.2
Heinrich, T.3
Varrone, A.4
Gulyas, B.5
Toth, M.6
-
38
-
-
84869021291
-
Development of positron emission tomography beta-amyloid plaque imaging agents
-
PID: 23026364, 10.1053/j.semnuclmed.2012.07.001
-
Mathis CA, Mason NS, Lopresti BJ, Klunk WE. Development of positron emission tomography beta-amyloid plaque imaging agents. Semin Nucl Med. 2012;42:423–32. doi:10.1053/j.semnuclmed.2012.07.001.
-
(2012)
Semin Nucl Med.
, vol.42
, pp. 423-432
-
-
Mathis, C.A.1
Mason, N.S.2
Lopresti, B.J.3
Klunk, W.E.4
-
39
-
-
0021020662
-
Relationship between lipophilicity and brain extraction of C-11 labeled radiopharmaceuticals
-
COI: 1:CAS:528:DyaL2cXhvFynsg%3D%3D
-
Dischino D, Welch M, Kilbourn M, Raichle M. Relationship between lipophilicity and brain extraction of C-11 labeled radiopharmaceuticals. J Nucl Med. 1983;24:1030–8.
-
(1983)
J Nucl Med.
, vol.24
, pp. 1030-1038
-
-
Dischino, D.1
Welch, M.2
Kilbourn, M.3
Raichle, M.4
-
40
-
-
0029742199
-
Correlative memory deficits, Aß elevation, and amyloid plaques in transgenic mice
-
COI: 1:CAS:528:DyaK28XmtVyns7c%3D, PID: 8810256
-
Hsiao K, Chapman P, Nilsen S, Eckman S, Harigaya Y, Younkin S, et al. Correlative memory deficits, Aß elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99–102.
-
(1996)
Science.
, vol.274
, pp. 99-102
-
-
Hsiao, K.1
Chapman, P.2
Nilsen, S.3
Eckman, S.4
Harigaya, Y.5
Younkin, S.6
-
41
-
-
0032886415
-
Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes
-
COI: 1:CAS:528:DyaK1MXltFShsbo%3D, PID: 10448051, 10.1006/nbdi.1999.0243
-
McGowan E, Sanders S, Iwatsubo T, Takeuchi A, Saido T, Zehr C, et al. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol Dis. 1999;6:231–44. doi:10.1006/nbdi.1999.0243.
-
(1999)
Neurobiol Dis.
, vol.6
, pp. 231-244
-
-
McGowan, E.1
Sanders, S.2
Iwatsubo, T.3
Takeuchi, A.4
Saido, T.5
Zehr, C.6
-
42
-
-
0031914718
-
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
-
COI: 1:CAS:528:DyaK1cXjt1OhsA%3D%3D, PID: 9427614
-
Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med. 1998;4:97–100.
-
(1998)
Nat Med.
, vol.4
, pp. 97-100
-
-
Holcomb, L.1
Gordon, M.N.2
McGowan, E.3
Yu, X.4
Benkovic, S.5
Jantzen, P.6
-
43
-
-
2542584749
-
Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice
-
COI: 1:CAS:528:DC%2BD2cXlsVCktbc%3D, PID: 15174014, 10.1002/ana.20101
-
Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Ann Neurol. 2004;55:801–14. doi:10.1002/ana.20101.
-
(2004)
Ann Neurol.
, vol.55
, pp. 801-814
-
-
Trinchese, F.1
Liu, S.2
Battaglia, F.3
Walter, S.4
Mathews, P.M.5
Arancio, O.6
-
44
-
-
84881392145
-
Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease
-
COI: 1:CAS:528:DC%2BC3sXhsVejsr%2FO, PID: 23833271, 10.2967/jnumed.112.110163
-
Snellman A, Lopez-Picon FR, Rokka J, Salmona M, Forloni G, Scheinin M, et al. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease. J Nucl Med. 2013;54:1434–41. doi:10.2967/jnumed.112.110163.
-
(2013)
J Nucl Med.
, vol.54
, pp. 1434-1441
-
-
Snellman, A.1
Lopez-Picon, F.R.2
Rokka, J.3
Salmona, M.4
Forloni, G.5
Scheinin, M.6
-
45
-
-
84879911625
-
Longitudinal assessment of cerebral beta-amyloid deposition in mice overexpressing Swedish mutant beta-amyloid precursor protein using 18F-florbetaben PET
-
COI: 1:CAS:528:DC%2BC3sXht1WitrrF, PID: 23729696, 10.2967/jnumed.112.114660
-
Rominger A, Brendel M, Burgold S, Keppler K, Baumann K, Xiong G, et al. Longitudinal assessment of cerebral beta-amyloid deposition in mice overexpressing Swedish mutant beta-amyloid precursor protein using 18F-florbetaben PET. J Nucl Med. 2013;54:1127–34. doi:10.2967/jnumed.112.114660.
-
(2013)
J Nucl Med.
, vol.54
, pp. 1127-1134
-
-
Rominger, A.1
Brendel, M.2
Burgold, S.3
Keppler, K.4
Baumann, K.5
Xiong, G.6
-
46
-
-
84857959777
-
Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer’s disease
-
COI: 1:CAS:528:DC%2BC38XktlSktr0%3D, PID: 22427802, 10.1371/journal.pone.0031310
-
Manook A, Yousefi BH, Willuweit A, Platzer S, Reder S, Voss A, et al. Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer’s disease. PLoS One. 2012;7:e31310. doi:10.1371/journal.pone.0031310.
-
(2012)
PLoS One.
, vol.7
, pp. e31310
-
-
Manook, A.1
Yousefi, B.H.2
Willuweit, A.3
Platzer, S.4
Reder, S.5
Voss, A.6
-
47
-
-
84867356027
-
Vaccine development to treat Alzheimer’s disease neuropathology in APP/PS1 transgenic mice
-
PID: 23024882, 10.1155/2012/376138
-
Carrera I, Etcheverria I, Fernandez-Novoa L, Lombardi V, Cacabelos R, Vigo C. Vaccine development to treat Alzheimer’s disease neuropathology in APP/PS1 transgenic mice. Int J Alzheimers Dis. 2012;2012:376138. doi:10.1155/2012/376138.
-
(2012)
Int J Alzheimers Dis.
, vol.2012
, pp. 376138
-
-
Carrera, I.1
Etcheverria, I.2
Fernandez-Novoa, L.3
Lombardi, V.4
Cacabelos, R.5
Vigo, C.6
-
48
-
-
84868319492
-
Intravenous delivery of targeted liposomes to amyloid-beta pathology in APP/PSEN1 transgenic mice
-
COI: 1:CAS:528:DC%2BC38XhslWjsLnF, PID: 23119043, 10.1371/journal.pone.0048515
-
Tanifum EA, Dasgupta I, Srivastava M, Bhavane RC, Sun L, Berridge J, et al. Intravenous delivery of targeted liposomes to amyloid-beta pathology in APP/PSEN1 transgenic mice. PLoS One. 2012;7:e48515. doi:10.1371/journal.pone.0048515.
-
(2012)
PLoS One.
, vol.7
, pp. e48515
-
-
Tanifum, E.A.1
Dasgupta, I.2
Srivastava, M.3
Bhavane, R.C.4
Sun, L.5
Berridge, J.6
-
49
-
-
35348821915
-
Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer’s disease enabled by positron emission tomography
-
COI: 1:CAS:528:DC%2BD2sXht1Wnsb7J, PID: 17928437, 10.1523/JNEUROSCI.0673-07.2007
-
Maeda J, Ji B, Irie T, Tomiyama T, Maruyama M, Okauchi T, et al. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer’s disease enabled by positron emission tomography. J Neurosci. 2007;27:10957–68. doi:10.1523/JNEUROSCI.0673-07.2007.
-
(2007)
J Neurosci.
, vol.27
, pp. 10957-10968
-
-
Maeda, J.1
Ji, B.2
Irie, T.3
Tomiyama, T.4
Maruyama, M.5
Okauchi, T.6
|